NAM logo
  • site map
  • contact
  • advanced search
  • Home
  • News
  • Treatment & Care
  • HIV Worldwide
  • Living with HIV
  • Preventing HIV
  • Organisations
  • HIV Basics
  • About Us
 
Treatment & Care
  • español
  • français
  • português
  • pусский
HIV treatment during pregnancy
  • Antiretroviral therapy during pregnancy
    • Guidelines for treatment during pregnancy
      • Pregnant women who are therapy-naive
      • Pregnant women already on ARV therapy
      • Prophylactic ART for PMTCT
      • Women who present in labour with no prior therapy
      • Care in the absence of ART during pregnancy and delivery
      • ART for women after delivery
      • Monitoring
      • Anaemia
      • United Kingdom guidelines
      • United States guidelines
    • Preventing mother-to-child transmission of HIV
      • Breastfeeding
        • Use of ART while breastfeeding
          • Other PMTCT strategies
          • Effect of breastfeeding on infant health
            • Impact of breastfeeding on the mother's health
            • Supplementation in pregnancy and breastfeeding
            support our work today
            YOU ARE HERE
            • > Home
              • > Treatment & Care
                • > Treatment & Care
                  • > HIV treatment during pregnancy

            Guidelines for treatment during pregnancy

            printer-friendly versionsend to a friendglossarycomment

            • Pregnant women who are therapy-naive
            • Pregnant women already on ARV therapy
            • Prophylactic ART for PMTCT
            • Women who present in labour with no prior therapy
            • Care in the absence of ART during pregnancy and delivery
            • ART for women after delivery
            • Monitoring
            • Anaemia
            • United Kingdom guidelines
            • United States guidelines

            latest aidsmap news

            • HIV prevalence may decline because the most vulnerable are infected and die first
            • Lack of perceived need for HIV treatment associated with poor adherence
            • TB doesn't always increase HIV viral load
            • New 75mg darunavir tablet approved by FDA for use by HIV-positive children
            • Thyroid checks recommended for people with HIV
            • Knighthood for head of UK HIV charity
            • Gay men often not accessing PEP despite risk of HIV exposure
            • Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
            • Internalised homophobia leads to sexual risk taking by HIV-positive gay men
            • Most gay men willing to consider PrEP for possible HIV exposure
             
            • Contact NAM
            • Get Email Updates
            • Disclaimer
            • Copyright
            • Developed By NAM